Literature DB >> 1206480

Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

H G Boxenbaum, I Berkersky, V Mattaliano, S A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1206480     DOI： 10.1007/bf01059476

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  33 in total

1.  The stability of isoniazid in serum stored in the frozen state.

Authors:  J H PETERS; R C GOOD
Journal:  Am Rev Respir Dis       Date:  1962-10

2.  Deterioration of isoniazid in frozen serum samples: a confirmatory note.

Authors:  J W JENNE
Journal:  Am Rev Respir Dis       Date:  1961-06

3.  A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.

Authors:  J W JENNE; F M MACDONALD; E MENDOZA
Journal:  Am Rev Respir Dis       Date:  1961-09

4.  Stability of isoniazid in aqueous solutions and plasma.

Authors:  N F POOLE; A E MEYER
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

5.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

Review 6.  Pharmacogenetics.

Authors:  E S Vesell
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

7.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

8.  Determination of isoniazid and metabolites in biological fluids.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

9.  Half-lives of isoniazid and salicylic acid in serum and their modification by different drugs in psychiatric patients.

Authors:  M J Mattila; S Takki
Journal:  Ann Med Exp Biol Fenn       Date:  1969

10.  Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.

Authors:  K V Rao; D A Mitchison; N G Nair; K Prema; S P Tripathy
Journal:  Br Med J       Date:  1970-08-29
View more
  7 in total

1.  Microdialysis sampling for determination of plasma protein binding of drugs.

Authors:  A M Herrera; D O Scott; C E Lunte
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

Review 2.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 3.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

4.  Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254.

Authors:  J Dhillon; D A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

6.  Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

Authors:  T B Vree; W J O'Reilly; Y A Hekster; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

7.  Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.

Authors:  A D Hutchings; R D Monie; B P Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.